Clindamycin phosphate

This classification denotes a lincosamide antibiotic with the molecular formula C18H34ClN2O8PS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EH6D7113I8, chemically known as l-threo-.alpha.-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2s-trans)-, but more generally known as clindamycin phosphate, which bears US NIH Compound Identifier 29029. European Medicines Agency schedules clindamycin phosphate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06665MIG. Most nations, for tariff purposes, schedule clindamycin phosphate under HS 29419000. Clindamycin phosphate bears US NLM identifiers UMLS ID C0055881 and NCI Concept Code C47978. SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@H](C)CL.